K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate von Smith, B Douglas, Kasamon, Yvette L, Kowalski, Jeanne, Gocke, Christopher, Murphy, Kathleen, Miller, Carole B, Garrett-Mayer, Elizabeth, Tsai, Hua-Ling, Qin, Lu, Chia, Christina, Biedrzycki, Barbara, Harding, Thomas C, Tu, Guang Haun, Jones, Richard, Hege, Kristen, Levitsky, Hyam I

Volltext